Trials / Conditions / Acute Lymphoblastic Leukemia in Remission

Acute Lymphoblastic Leukemia in Remission

23 registered clinical trials studyying Acute Lymphoblastic Leukemia in Remission — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion NCT05236764	Baylor College of Medicine	N/A
Recruiting	MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880	Medical College of Wisconsin	N/A
Withdrawn	Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis Af NCT03602898	Fred Hutchinson Cancer Center	Phase 2
Active Not Recruiting	Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leu NCT04232241	Universitätsklinikum Hamburg-Eppendorf	Phase 2
Recruiting	211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Ris NCT03670966	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Withdrawn	Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab NCT03982992	Ludwig-Maximilians - University of Munich	Phase 2
Completed	VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies NCT03885947	Alla Keyzner	Phase 1
Withdrawn	Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Bloo NCT03438344	City of Hope Medical Center	Phase 2
Active Not Recruiting	CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Tran NCT03560752	City of Hope Medical Center	Phase 1
Unknown	CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment NCT05381662	Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd	Phase 1 / Phase 2
Suspended	Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treatin NCT03494569	City of Hope Medical Center	Phase 1
Completed	Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation NCT03483324	Angiocrine Bioscience	Phase 1
Terminated	Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia NCT03488225	M.D. Anderson Cancer Center	Phase 2
Completed	Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients W NCT03096782	M.D. Anderson Cancer Center	Phase 2
Recruiting	Personalized NK Cell Therapy in CBT NCT02727803	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV a NCT02506933	City of Hope Medical Center	Phase 2
Completed	Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Rela NCT02220985	Fred Hutchinson Cancer Center	Phase 2
Completed	Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in R NCT02083250	M.D. Anderson Cancer Center	Phase 1
Unknown	NK Cells in Cord Blood Transplantation NCT01619761	M.D. Anderson Cancer Center	Phase 1
Completed	Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating NCT01690520	Nohla Therapeutics, Inc.	Phase 2
Terminated	Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT01028716	Fred Hutchinson Cancer Center	Phase 2
Completed	Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer W NCT00796068	Fred Hutchinson Cancer Center	Phase 2
Completed	Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treatin NCT00075478	Fred Hutchinson Cancer Center	Phase 3